Correlation Between Shanghai Rongtai and Liaoning Chengda

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shanghai Rongtai and Liaoning Chengda at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Rongtai and Liaoning Chengda into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shanghai Rongtai Health and Liaoning Chengda Biotechnology, you can compare the effects of market volatilities on Shanghai Rongtai and Liaoning Chengda and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Rongtai with a short position of Liaoning Chengda. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Rongtai and Liaoning Chengda.

Diversification Opportunities for Shanghai Rongtai and Liaoning Chengda

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Shanghai and Liaoning is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Rongtai Health and Liaoning Chengda Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Liaoning Chengda Bio and Shanghai Rongtai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Rongtai Health are associated (or correlated) with Liaoning Chengda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Liaoning Chengda Bio has no effect on the direction of Shanghai Rongtai i.e., Shanghai Rongtai and Liaoning Chengda go up and down completely randomly.

Pair Corralation between Shanghai Rongtai and Liaoning Chengda

Assuming the 90 days trading horizon Shanghai Rongtai Health is expected to under-perform the Liaoning Chengda. In addition to that, Shanghai Rongtai is 1.51 times more volatile than Liaoning Chengda Biotechnology. It trades about -0.03 of its total potential returns per unit of risk. Liaoning Chengda Biotechnology is currently generating about -0.02 per unit of volatility. If you would invest  3,150  in Liaoning Chengda Biotechnology on November 9, 2024 and sell it today you would lose (526.00) from holding Liaoning Chengda Biotechnology or give up 16.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Shanghai Rongtai Health  vs.  Liaoning Chengda Biotechnology

 Performance 
       Timeline  
Shanghai Rongtai Health 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Shanghai Rongtai Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Shanghai Rongtai is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Liaoning Chengda Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Liaoning Chengda Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Shanghai Rongtai and Liaoning Chengda Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shanghai Rongtai and Liaoning Chengda

The main advantage of trading using opposite Shanghai Rongtai and Liaoning Chengda positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Rongtai position performs unexpectedly, Liaoning Chengda can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Liaoning Chengda will offset losses from the drop in Liaoning Chengda's long position.
The idea behind Shanghai Rongtai Health and Liaoning Chengda Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device